198 related articles for article (PubMed ID: 36396974)
1. Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line.
Rush CM; Blanchard Z; Polaski JT; Osborne KS; Osby K; Vahrenkamp JM; Yang CH; Lum DH; Hagan CR; Leslie KK; Pufall MA; Thiel KW; Gertz J
Sci Rep; 2022 Nov; 12(1):19731. PubMed ID: 36396974
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
Wormke M; Castro-Rivera E; Chen I; Safe S
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
[TBL] [Abstract][Full Text] [Related]
5. Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa).
Lovely LP; Appa Rao KB; Gui Y; Lessey BA
J Steroid Biochem Mol Biol; 2000 Nov; 74(4):235-41. PubMed ID: 11162929
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
Dai H; Zhang P; Zhao S; Zhang J; Wang B
Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
[TBL] [Abstract][Full Text] [Related]
7. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
[TBL] [Abstract][Full Text] [Related]
8. Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing.
Tamm-Rosenstein K; Simm J; Suhorutshenko M; Salumets A; Metsis M
PLoS One; 2013; 8(7):e68907. PubMed ID: 23874806
[TBL] [Abstract][Full Text] [Related]
9. The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells.
Farnell YZ; Ing NH
J Steroid Biochem Mol Biol; 2003 Mar; 84(4):453-61. PubMed ID: 12732290
[TBL] [Abstract][Full Text] [Related]
10. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
11. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
Hevir-Kene N; Rižner TL
Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
[TBL] [Abstract][Full Text] [Related]
12. Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
Ring KL; Yates MS; Schmandt R; Onstad M; Zhang Q; Celestino J; Kwan SY; Lu KH
Int J Gynecol Cancer; 2017 Jun; 27(5):854-862. PubMed ID: 28498246
[TBL] [Abstract][Full Text] [Related]
13. Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.
Horvath G; Leser G; Helou K; Henriksson M
Gynecol Oncol; 2002 Feb; 84(2):271-9. PubMed ID: 11812086
[TBL] [Abstract][Full Text] [Related]
14. Hormonal modulation of Ishikawa cells during three-dimensional growth in vitro.
Pinelli DM; Drake J; Williams MC; Cavanagh D; Becker JL
J Soc Gynecol Investig; 1998; 5(4):217-23. PubMed ID: 9699181
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
Xu Y; Tong J; Ai Z; Wang J; Teng Y
J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.
Lessey BA; Ilesanmi AO; Castelbaum AJ; Yuan L; Somkuti SG; Chwalisz K; Satyaswaroop PG
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):31-9. PubMed ID: 9009235
[TBL] [Abstract][Full Text] [Related]
17. Assessing Estrogen-Induced Proliferative Response in an Endometrial Cancer Cell Line Using a Universally Applicable Methodological Guide.
Parkes C; Kamal A; Valentijn AJ; Alnafakh R; Gross SR; Barraclough R; Moss D; Kirwan J; Hapangama DK
Int J Gynecol Cancer; 2018 Jan; 28(1):122-133. PubMed ID: 28953135
[TBL] [Abstract][Full Text] [Related]
18. Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin.
Meng YG; Han WD; Zhao YL; Huang K; Si YL; Wu ZQ; Mu YM
Cell Res; 2007 Oct; 17(10):869-80. PubMed ID: 17893710
[TBL] [Abstract][Full Text] [Related]
19. [Separation and characterization of estrogen independent endometrial cancer cell line originated from Ishikawa strain].
Shirakawa T; Sakamoto H; Satoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):139-46. PubMed ID: 8718550
[TBL] [Abstract][Full Text] [Related]
20. ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.
Tong JS; Zhang QH; Wang ZB; Li S; Yang CR; Fu XQ; Hou Y; Wang ZY; Sheng J; Sun QY
PLoS One; 2010 Nov; 5(11):e15408. PubMed ID: 21079811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
